Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Protalix BioTherapeutics
Protalix BioTherapeutics
Pfizer, Protalix Fail to Win FDA Approval of Cerezyme Rival
Bloomberg
Fri, 02/25/11 - 08:41 am
FDA
Protalix BioTherapeutics
Pfizer
Cerezyme
taliglucerase alfa
Shire
Genzyme
FDA Catalyst Trade: Protalix BioTherapeutics
Seeking Alpha
Wed, 02/2/11 - 12:02 pm
FDA
Protalix BioTherapeutics
Pfizer
UPLYSO
Biotech Calendar: FDA Drug Approvals in 2011
TheStreet.com
Mon, 12/13/10 - 12:26 pm
MannKind
Afrezza
Alimera
pSivida
Seattle Genetics
brentuximab vedotin
Illuvien
AstraZeneca
Zictifa
Clinical Data
Vilazodone
Orexigen
Contrave
Bristol-Myers Squibb
Yervoy
Pfizer
Protalix BioTherapeutics
UPLYSO
Xiafaxan
Salix
Human Genome Sciences
Benlysta
Dendreon
Provenge
InterMune
Esbriet
Cell Therapeutics
pixantrone
Forest Labs
Daxas
MELA Sciences
MelaFind
XenoPort
GSK
Horizant
Spectrum Pharmaceuticals
Fusilev
Adventrx
Vertex Pharmaceuticals
Telaprevir
Pharmacyclics: Showing Promise
Seeking Alpha
Tue, 11/16/10 - 12:03 pm
Pharmacyclics
Pfizer
Protalix BioTherapeutics
Sanofi
Genzyme
The Pros of Protalix
Seeking Alpha
Wed, 10/13/10 - 11:59 am
Protalix BioTherapeutics
Teva Pharmaceuticals
Gaucher disease
Pfizer Acts on Growing Interest in Niche Drugs
Seeking Alpha
Fri, 09/3/10 - 08:06 am
Protalix BioTherapeutics
Pfizer
UPLYSO
M&A
tafamidis meglumine
FoldRx
Six Trades on FDA, Clinical Trial Binary Events
Seeking Alpha
Tue, 07/13/10 - 09:14 pm
BioSante
LibiGel
testosterone
EntreMed
ENMD-2076
cancer
Protalix BioTherapeutics
UPLYSO
ovarian cancer
Vivus
Qnexa
obesity
EMD 640744
cancer vaccines
Target Date for Protalix Drug
Yahoo/Zacks.com
Tue, 07/13/10 - 11:16 am
Protalix BioTherapeutics
Gaucher disease
Ulypso
Good News for Shire
Yahoo/Zacks.com
Mon, 06/28/10 - 01:39 pm
Shire
Pfizer
Protalix BioTherapeutics
Vpriv
Gaucher disease
What Investors Think About Protalix BioTherapeutics
Motley Fool
Mon, 06/21/10 - 12:08 pm
investors
Protalix BioTherapeutics
Consent Decree Likely for Genzyme
Yahoo/Zacks.com
Fri, 03/26/10 - 09:28 am
Genzyme
consent decree
Protalix BioTherapeutics
Who Benefits From Genzyme’s Troubles
Minyanville
Wed, 03/24/10 - 04:55 pm
Genzyme
Abbott Laboratories
Schering Plough
Shire
Protalix BioTherapeutics
Pfizer
Genzyme rivals unleash barrage of promising Gaucher data
Fierce Biotech
Fri, 02/12/10 - 09:04 am
Genzyme
Gaucher disease
Shire
Protalix BioTherapeutics
Protalix shares dip as FDA poses new Gaucher drug query
Fierce Biotech
Tue, 02/2/10 - 10:06 am
Gaucher disease
Protalix BioTherapeutics
FDA
No Holiday For Biopharma P & A
CNBC
Thu, 12/3/09 - 03:12 pm
partnerships
M&A
Pfizer
Protalix BioTherapeutics
Targacept
AstraZeneca
Merck
Amgen
GSK
Human Genome Sciences
Why Pfizer's Deal with Protalix Is Bad News for Big Pharma Sales Reps
BNET Pharma
Wed, 12/2/09 - 09:31 am
drug reps
Protalix BioTherapeutics
Pfizer
Ulypso
Pfizer, Protalix agree deal on taliglucerase
Marketwatch
Tue, 12/1/09 - 09:17 am
partnerships
Protalix BioTherapeutics
Pfizer
taliglucerase
Gaucher disease
On the Radar: November's biotech stocks to watch
Fierce Biotech
Wed, 11/18/09 - 12:19 pm
biotech
Cadence Pharmaceuticals
Micromet
Momenta
Pharmasset
Protalix BioTherapeutics
Will Pfizer buy Protalix?
Globes,Israel
Mon, 11/2/09 - 08:37 am
Pfizer
Protalix BioTherapeutics
M&A
Israel
Protalix says Gaucher drug met goals in trial
Yahoo/AP
Thu, 10/15/09 - 09:03 am
Gaucher disease
Protalix BioTherapeutics
drug trials
Ulypso
Pages
« first
‹ previous
1
2
3
4
next ›
last »